Neuraxis, Inc. (NRXS) is a biotechnology company listed on AMEX.
Latest reported NRXS revenue for 2025-12-31 was $3.6M. Net income was -$7.8M. Revenue was up 32.9% from 2024-12-31 to 2025-12-31. NRXS currently screens at market cap $83.1M.
Use this NRXS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NRXS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NRXS SEC filings page. Lician reads the product cache first so this HTML stays unique to Neuraxis, Inc. even when a live quote feed is slow.
Latest cached year on this hub. Full NRXS income, balance, and cash tables.